Withdrawal severity and addiction severity measure different clinical issues, helping determine whether someone needs medical detox, residential treatment, outpatient care, or continued recovery support afterward.
Brixadi and Sublocade provide long-acting buprenorphine treatment for opioid use disorder, with different dosing schedules, initiation pathways, strengths, and options for ongoing recovery support needs.
Addiction treatment planning should address housing after rehab, including extended care, sober living, family homes, outpatient treatment, and recovery support for long-term stability and independence.